组织芯片

乳腺癌组织芯片，系列13，不与BRC1501到BRC1508或BRC15010到BRC15011重复，150芯，包括正常/良性（5例）和癌（70例）组织提供分级，TNM分期，和AR，ER，PR，HER2，P53，EGFR，Ki67 IHC数据。

芯片编号	CR-XBRC15013
芯片名称	BRC15013乳腺癌，75例，150芯（1.1mm），系列13
芯片说明	乳腺癌组织芯片，系列13，不与BRC1501到BRC1508或BRC15010到BRC15011重复，150芯，包括正常/良性（5例）和癌（70例）组织提供分级，TNM分期，和AR，ER，PR，HER2，P53，EGFR，Ki67 IHC数据。
点数:	150芯
例数:	75例
组织固定方式:	福尔马林固定24h
QA/QC:	HE染色和IHC染色
应用:	常规组织学操作包括免疫组织化学(IHC)和原位杂交(ISH)，可以在我们的技术支持页面找到操作流程。
注意事项:	1.收到产品后请常温保存，并在24个月内使用，2.请在实验前60°烤片30分钟，3.请选择温和的修复方式，以免造成组织脱落。
位置	年龄	性别	标本部位	病理分类	病理分级	TNM_T	TNM_N	TNM_M	备注
A1,B1	33	F	乳腺，Breast	增生；Hyperplasia
A2,B2	35	F	乳腺，Breast	增生；Hyperplasia
A3,B3	44	F	乳腺，Breast	乳腺腺病；Adenosis of breast
A4,B4	24	F	乳腺，Breast	腺瘤；Adenoma
A5,B5	25	F	乳腺，Breast	腺瘤；Adenoma
A6,B6	54	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T4	N2	M0
A7,B7	61	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N2	M0
A8,B8	41	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N0	M0
A9,B9	45	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T2	N1	M0
A10,B10	54	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N0	M0
A11,B11	39	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T3	N3	M0
A12,B12	53	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T2	N2	M0
A13,B13	42	F	乳腺，Breast	原位癌；Carcinoma in situ
A14,B14	58	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N0	M0
A15,B15	49	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T4	N0	M0
C1,D1	48	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N1	M0
C2,D2	53	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T2	N3	M0
C3,D3	48	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T2	N1	M0
C4,D4	35	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N0	M0
C5,D5	42	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T2	N0	M0
C6,D6	61	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T2	N0	M0
C7,D7	62	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N2	M0
C8,D8	52	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T2	N1	M0
C9,D9	45	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N1	M0
C10,D10	55	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	I	T4	N2	M0
C11,D11	57	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T2	N2	M0
C12,D12	74	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N0	M0
C13,D13	56	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N1	M0
C14,D14	40	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II~III	T2	N2	M0
C15,D15	40	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T2	N1	M0
E1,F1	52	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T2	N1	M0
E2,F2	45	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T2	N0	M0
E3,F3	60	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T4	N1	M0
E4,F4	80	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T4	N0	M0
E5,F5	46	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N1	M0
E6,F6	64	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T3	N0	M0
E7,F7	55	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N0	M0
E8,F8	56	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N1	M0
E9,F9	59	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N0	M0
E10,F10	59	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N0	M0
E11,F11	40	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T2	N2	M0
E12,F12	65	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T4	N2	M0
E13,F13	51	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N0	M0
E14,F14	32	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N0	M0
E15,F15	53	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T2	N0	M0
G1,H1	38	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N1	M0
G2,H2	53	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N3	M0
G3,H3	61	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T4	N2	M0
G4,H4	54	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T4	N3	M0
G5,H5	40	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T2	N0	M0
G6,H6	80	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N0	M0
G7,H7	50	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T2	N0	M0
G8,H8	41	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N3	M0
G9,H9	49	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T3	N2	M0
G10,H10	45	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N3	M0
G11,H11	51	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N3	M0
G12,H12	59	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T4	N2	M0
G13,H13	30	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N3	M0
G14,H14	56	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N1	M0
G15,H15	33	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T2	N0	M0
I1,J1	61	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T3	N0	M0
I2,J2	50	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T4	N3	M0
I3,J3	79	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T4	N1	M0
I4,J4	66	F	乳腺，Breast	浸润性小叶癌；Invasive lobular carcinoma	II	T4	N0	M0
I5,J5	60	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T2	N0	M0
I6,J6	49	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	III	T3	N2	M0
I7,J7	51	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N0	M0
I8,J8	66	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T2	N2	M0
I9,J9	58	F	乳腺，Breast	浸润性导管癌；Invasive ductal carcinoma	II	T4	N1	M0
I10,J10	47	F	乳腺，Breast	原位癌；Carcinoma in situ
I11,J11	45	F	乳腺，Breast	腺样囊性癌；Adenoid cystic carcinoma		T2	N0	M0
I12,J12	39	F	乳腺，Breast	浸润性小叶癌；Invasive lobular carcinoma		T2	N0	M0
I13,J13	38	F	乳腺，Breast	浸润性小叶癌；Invasive lobular carcinoma		T2	N0	M0
I14,J14	49	F	乳腺，Breast	浸润性小叶癌；Invasive lobular carcinoma		T3	N2	M0
I15,J15	50	F	乳腺，Breast	浸润性小叶癌；Invasive lobular carcinoma		T4	N3	M0